820 results on '"Tamanoi, Fuyuhiko"'
Search Results
2. Development and characterization of magnetic-based biodegradable periodic mesoporous organosilica nanoparticles for enhanced biomedical applications
3. History of The Enzymes: 1950–2023
4. Preface: History of The Enzymes, Current Topics and Future Perspectives
5. Engineering biodegradable periodic mesoporous functionalized-organosilica nanocarriers for efficient paclitaxel delivery
6. An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation
7. Magnetic Nanoparticles and Alternating Magnetic Field for Cancer Therapy
8. Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer.
9. Summary of volume 51: DNA damage and double-strand breaks
10. The enzymes second edition part 1
11. Overview of DNA damage and double-strand breaks
12. The enzymes second edition part 2
13. The enzymes first edition
14. Inhibition of DNA synthesis and cancer therapies
15. Preface
16. Auger electrons and DNA double-strand breaks studied by using iodine-containing chemicals
17. Facile synthesis of biodegradable mesoporous functionalized-organosilica nanoparticles for enhancing the anti-cancer efficiency of cordycepin
18. Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models
19. Reducing particle size of biodegradable nanomaterial for efficient curcumin loading
20. Preface
21. Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy
22. Significance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesis
23. Significance of filamin A in mTORC2 function in glioblastoma
24. Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden
25. Iodine containing porous organosilica nanoparticles trigger tumor spheroids destruction upon monochromatic X-ray irradiation: DNA breaks and K-edge energy X-ray
26. Magnetic Nanoparticles and Alternating Magnetic Field for Cancer Therapy
27. Correction to: Magnetic Nanoparticles and Alternating Magnetic Field for Cancer Therapy
28. GTP-Binding Protein Rheb
29. Protein Farnesyltransferase
30. Recent progress in the study of the Rheb family GTPases
31. Preface
32. Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer
33. In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells
34. Correction to: Magnetic Nanoparticles and Alternating Magnetic Field for Cancer Therapy
35. Relationship between the glutathione-responsive degradability of thiol-organosilica nanoparticles and the chemical structures
36. PAK1 kinase promotes cell motility and invasiveness through CRK-II serine phosphorylation in non-small cell lung cancer cells.
37. A Tagging-via-Substrate Technology for Detection and Proteomics of Farnesylated Proteins
38. Data from De-Repression of PDGFRβ Transcription Promotes Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Glioblastoma Patients
39. Supplementary Figure 1 from De-Repression of PDGFRβ Transcription Promotes Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Glioblastoma Patients
40. Supplementary Figure 2 from De-Repression of PDGFRβ Transcription Promotes Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Glioblastoma Patients
41. Inhibitors of Ras/Raf-1 Interaction Identified by Two-Hybrid Screening Revert Ras-Dependent Transformation Phenotypes in Human Cancer Cells
42. Recent excitements in the study of the CAM assay
43. Preface
44. Farnesyltransferase Inhibitors Induce Cytochrome c Release and Caspase 3 Activation Preferentially in Transformed Cells
45. Farnesyltransferase Inhibitors Induce Dramatic Morphological Changes of KNRK Cells that are Blocked by Microtubule Interfering Agents
46. Isolation and characterization of the primary epithelial breast cancer cells and the adjacent normal epithelial cells from Iranian women’s breast cancer tumors
47. Data from In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I
48. Supplementary Data from In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I
49. Data from AMP-Activated Protein Kinase Signaling Results in Cytoplasmic Sequestration of p27
50. Supplementary Figures 1-2, Table 1 from AMP-Activated Protein Kinase Signaling Results in Cytoplasmic Sequestration of p27
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.